Abstract
Papillary thyroid cancer (PTC) is the most prevalent histological type of thyroid cancer (TC) worldwide. Although tumor metastasis occurs in regional lymph nodes, distant metastasis (DM) may also occur. Radioactive iodine (RAI) therapy is an effective treatment for TC; however, resistance to RAI occurs in patients with DM. Therefore, in this study, we investigated the efficacy of DM-related biomarkers as therapeutic targets for PTC therapy. ABCA1 expression was higher in aggressive BCPAP cells than in other PTC cells in terms of migration and invasion capacity. The knockdown of ABCA1 substantially decreased the expression of the epithelial–mesenchymal transition (EMT) marker, N-cadherin, and EMT regulator (ZEB1), resulting in suppressed migration and invasion of BCPAP cells. ABCA1 knockdown also reduced ERK activity and Fra-1 expression, which correlated with the effects of an ERK inhibitor or siRNA-mediated inhibition of ERK or Fra-1 expression. Furthermore, ABCA1-knocked-down BCPAP cells suppressed cell migration and invasion by reducing Fra-1 recruitment to Zeb1 promoter; lung metastasis was not observed in mice injected with ABCA1-knocked-down cells. Overall, our findings suggest that ABCA1 regulates lung metastasis in TC cells.
Funder
Korea Institute of Radiological and Medical Sciences
Research fund of Hanyang University
Reference58 articles.
1. Annual report to the nation on the status of cancer, 1975–2014, featuring survival;Jemal;J. Natl. Cancer Inst.,2017
2. Clinical, pathological, and molecular profiling of radioactive iodine refractory differentiated thyroid cancer;Shobab;Thyroid,2019
3. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974–2013;Lim;JAMA,2017
4. Thyroid Carcinoma;Sherma;Lancet,2003
5. Rising incidence and incidence-based mortality of thyroid cancer in California, 2000–2017;Yan;J. Clin. Endocrinol. Metab.,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献